Back
Monopar Therapeutics Stock Price Chart
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
38
MNPR
Monopar Therapeutics
Last Price:
$32.65
Seasonality Move:
-14.17%
7 Day Trial
ALL ACCESS PASS
$
7
AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.52 | Sell |
| 20-day SMA: | 34.81 | Buy |
| 50-day SMA: | 38.09 | Sell |
| 200-day SMA: | 17.21 | Buy |
| 8-day EMA: | 38.23 | Sell |
| 20-day EMA: | 37.06 | Sell |
| 50-day EMA: | 35.2 | Buy |
| 200-day EMA: | 21.88 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 49.79 | Sell |
| Chaikin Money Flow: | 7569 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.05 - 39.15) | Buy |
| Bollinger Bands (100): | (19.96 - 39.78) | Buy |
Monopar Therapeutics Technical Analysis
| Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 36.41 while MNPR 8-day simple moving average is 39.52, which is a Sell signal.
-
The stock price of MNPR is 36.41 while Monopar Therapeutics 20-day SMA is 34.81, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 38.09 while MNPR share price is 36.41, making it a Sell technically.
-
MNPR stock price is 36.41 and Monopar Therapeutics 200-day simple moving average is 17.21, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
38
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $36.41. The Score for MNPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
192.2M
Price in USD:
36.41
Share Volume:
43.4K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
38
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 36.41 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 36.41 while MNPR 8-day exponential moving average is 38.23, which is a Sell signal.
-
The stock price of MNPR is 36.41 while Monopar Therapeutics 20-day EMA is 37.06, which makes it a Sell.
-
Monopar Therapeutics 50-day exponential moving average is 35.20 while MNPR share price is 36.41, making it a Buy technically.
-
MNPR stock price is 36.41 and Monopar Therapeutics 200-day simple moving average is 21.88, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.77 per share, and an increase next year of $3.30 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 0.82, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 49.79, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (30.05 - 39.15), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (19.96 - 39.78), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.